Smoking treatment interventions and policies to promote their use: A critical review

Nicotine and Tobacco Research

Volumn 3, Issue 4, 2001, Pages 299-310

  Friend, Karen ^a   Levy, David T ^b  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF BALTIMORE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; PUBLIC HEALTH INSURANCE; REVIEW; SMOKING; SMOKING CESSATION; TOBACCO;

COST-BENEFIT ANALYSIS; HEALTH POLICY; HEALTH PROMOTION; HUMANS; MENTAL HEALTH SERVICES; PUBLIC POLICY; SMOKING; SMOKING CESSATION;

EID: 0035185525     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/14622200110072165     Document Type: Review

References (103)

1. Tobacco and children: An economic evaluation of the medical effects of parental smoking
2. The cost-effectiveness of three smoking cessation programs
3. Spring Tobacco treatment services should be covered under managed care
4. Implementing tobacco tracking codes in an individual practice association or a network model health maintenance organization
5. Impact of promotion of the Great American Smokeout and availability of over-the-counter nicotine medications, 1996
6. Use of FDA-approved pharmacologic treatments for tobacco dependence in the United States: 1990-1998
7. Health behavior change in managed care: A status report
8. The Surgeon General's 1990 report on the health benefits of smoking cessation
9. Smoking cessation during previous year among adults-United States, 1990 and 1991
10. Cigarette smoking among adults-United States, 1992, and changes in definition of current cigarette smoking
11. Medical care expenditures attributable to cigarette smoking-United States, 1993
12. Health-care provider advice on tobacco use to persons aged 10-22 years-United States, 1993
13. Use of clinical preventive services by adults aged <65 years enrolled in health-maintenance organizations - United States, 1996
14. Counseling medical and dental patients about cigarette smoking: The impact of nicotine gum and chart reminders
15. Community Intervention Trial for Smoking Cessation (COMMIT): II. Changes in adult cigarette smoking prevalence
16. Nicotine gum: Does providing it free in a smoking cessation program alter success rates?
17. Cost-effectiveness of treating nicotine dependence: The Mayo Clinic experience
18. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation
19. Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992-1993
20. The cost-effectiveness of counseling smokers to quit
21. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization
22. Healthcare report cards and tobacco measures
23. An overview of tobacco measures
24. Morbidity and mortality in children associated with the use of tobacco products by other people
25. Initial symptoms of nicotine dependence in adolescents
26. Methods used to quit smoking in the United States: Do cessation programs help?
27. The effectiveness of the nicotine patch for smoking cessation: A meta-analysis
28. Helping Wisconsin women quit smoking: A successful collaboration
29. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling
30. Predictors of physicians' smoking cessation advice
31. Physician advice to quit smoking: Results from the 1990 California Tobacco Survey
32. Duration of smoking and success in quitting
33. Physician-initiated smoking cessation program: The National Cancer Institute trials
34. A population-based survey of patients' perceptions of health care provider-delivered smoking cessation interventions
35. A population-based survey of physician smoking cessation counseling practices
36. Characteristics and perceptions of nicotine patch users
37. Over the counter nicotine patch therapy for smoking cessation: Results from randomized, double-blind, placebo-controlled, and open label trials
38. Results of Hazelden Survey on Current and Former Smokers
39. Young smokers' attitudes about methods for quitting smoking: Barriers and benefits to using assisted methods
40. Nurse-assisted counseling for smokers in primary care
41. Near-sighted on nicotine? Coverage for smoking cessation products
42. Four beliefs that may impede progress in the treatment of smoking
43. Reduced smoking: An introduction and review of the evidence
44. Effect of cost on the self-administration and efficacy of nicotine gum: A preliminary study
45. Ability of smokers to reduce their smoking and its association with future smoking cessation
46. Recent advances in the pharmacotherapy of smoking
47. Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler
48. Making time for tobacco cessation counseling
49. Patterns of nicotine gum use in a health maintenance organization
50. Delivery rates for preventive services in 44 midwestern clinics
51. Nicotine dependency and adolescents: Preventing and treating
52. OTC nicotine patches: Effectiveness alone and with brief intervention
53. A simulation of the effects of youth initiation policies on overall cigarette use
54. Increasing taxes as a strategy to reduce cigarette use and deaths: Results of a simulation model
55. Short-term economic and health benefits of smoking cessation: Myocardial infarction and stroke
56. A randomized trial of physician training for smoking cessation
57. The feasibility of behavioral risk reduction in primary medical care
58. Results from the first annual survey on addressing tobacco in managed care
59. Cost-outcome analysis in injury prevention and control: A primer on methods
60. Cost-outcome analysis in injury prevention and control: 84 recent estimates for the U.S
61. Smoking cessation programs for pregnant women
62. Physician-delivered interventions for smoking cessation: Strategies for increasing effectiveness
63. Tobacco control activities of primary-care physicians in the Community Intervention Trial for Smoking Cessation
64. Helping pregnant smokers quit: Meeting the challenge in the next decade
65. Use of transdermal nicotine in a state-level prescription plan for the elderly
66. Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking
67. Nicotine patch use in the general population: Results from the 1993 California Tobacco Survey
68. Tobacco Control in California: Who's Winning the War? An Evaluation of the Tobacco Control Program, 1989-1996
69. Coverage for tobacco dependence treatments: Results of a randomized trial in California HMOs
70. Managed care for preventive services: A review of policy options
71. Medicaid coverage for tobacco dependence treatments
72. Tobacco cessation and youth: The feasibility of brief office interventions for adolescents
73. Public health benefit of over-the-counter nicotine medications
74. Tobacco dependence treatments: Review and prospectus
75. Physician advice for smoking cessation
76. Meta-analysis of efficacy of nicotine replacement therapies in smoking cessation
77. New Gallup survey reveals smokers' increased desire to kick the habit
78. Practical implication of recall bias
79. Incentivising, facilitating, and implementing an office tobacco cessation system
80. Nicotine patches in smoking cessation: A randomized trial among over-the-counter customers in Denmark
81. Group behavior therapy programmes for smoking cessation
82. The effects of computer-tailored smoking cessation messages in family practice settings
83. Community patterns of transdermal nicotine use and provider counseling
84. National patterns in the treatment of smokers by physicians
85. Drug coverage decisions: The role of dollars and values
86. Do dentists and physicians advise tobacco users to quit?
87. Race and education in relation to stopping smoking in the US: The CARDIA study
88. The impact of smoking and quitting on health care use
89. Accuracy of patient recall of opportunistic smoking advice in general practice
90. Cost effectiveness of smoking-cessation therapies: Interpretation of the evidence and implications for coverage
91. Health and economic implications of a work-site smoking-cessation program: A simulation analysis
92. The cost-effectiveness of the nicotine transdermal patch for smoking cessation
93. Are clinicians intervening with their patients who smoke? A 'real world' assessment of 45 clinics in the upper Midwest
94. Improving smoking cessation advice in Australian general practice: What do GPs suggest is needed?
95. Smoking cessation counseling with pregnant and postpartum women: A survey of community health center providers
96. Smoking cessation with and without assistance: A population-based analysis